IN2014DN08312A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN08312A IN2014DN08312A IN8312DEN2014A IN2014DN08312A IN 2014DN08312 A IN2014DN08312 A IN 2014DN08312A IN 8312DEN2014 A IN8312DEN2014 A IN 8312DEN2014A IN 2014DN08312 A IN2014DN08312 A IN 2014DN08312A
- Authority
- IN
- India
- Prior art keywords
- breast cancer
- relates
- present
- prognosis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261607316P | 2012-03-06 | 2012-03-06 | |
PCT/IB2013/001032 WO2013132354A2 (en) | 2012-03-06 | 2013-03-06 | Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN08312A true IN2014DN08312A (US06420169-20020716-C00020.png) | 2015-05-15 |
Family
ID=48626483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN8312DEN2014 IN2014DN08312A (US06420169-20020716-C00020.png) | 2012-03-06 | 2013-03-06 |
Country Status (6)
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3047037B1 (en) * | 2013-09-20 | 2019-11-27 | The Regents Of The University Of Michigan | Method for the analysis of radiosensitivity |
TWI582240B (zh) * | 2015-05-19 | 2017-05-11 | 鄭鴻鈞 | 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置 |
KR20240005121A (ko) * | 2015-12-11 | 2024-01-11 | 고쿠리츠다이가쿠호진 고치다이가쿠 | 췌장암 및 췌장관 내 유두상 점액성 종양의 마커 |
EP3891293A4 (en) * | 2018-12-08 | 2023-01-04 | PFS Genomics, Inc. | TRANSCRIPTOMIC TYPING FOR BREAST CANCER PROGNOSTIC |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4323546A (en) | 1978-05-22 | 1982-04-06 | Nuc Med Inc. | Method and composition for cancer detection in humans |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
EP0232967B1 (en) | 1986-01-10 | 1993-04-28 | Amoco Corporation | Competitive homogeneous assay |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5283174A (en) | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
US5225326A (en) | 1988-08-31 | 1993-07-06 | Research Development Foundation | One step in situ hybridization assay |
US5480784A (en) | 1989-07-11 | 1996-01-02 | Gen-Probe Incorporated | Nucleic acid sequence amplification methods |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
US5270184A (en) | 1991-11-19 | 1993-12-14 | Becton, Dickinson And Company | Nucleic acid target generation |
US5545524A (en) | 1991-12-04 | 1996-08-13 | The Regents Of The University Of Michigan | Compositions and methods for chromosome region-specific probes |
US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
US5714330A (en) | 1994-04-04 | 1998-02-03 | Lynx Therapeutics, Inc. | DNA sequencing by stepwise ligation and cleavage |
US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
US5695934A (en) | 1994-10-13 | 1997-12-09 | Lynx Therapeutics, Inc. | Massively parallel sequencing of sorted polynucleotides |
JP3189000B2 (ja) | 1994-12-01 | 2001-07-16 | 東ソー株式会社 | 特定核酸配列の検出方法 |
US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
US5710029A (en) | 1995-06-07 | 1998-01-20 | Gen-Probe Incorporated | Methods for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product |
US6121489A (en) | 1996-03-05 | 2000-09-19 | Trega Biosciences, Inc. | Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein |
DE69738687D1 (de) | 1996-04-12 | 2008-06-26 | Phri Properties Inc | Sonden, kits und assays |
US5770370A (en) | 1996-06-14 | 1998-06-23 | David Sarnoff Research Center, Inc. | Nuclease protection assays |
ATE363652T1 (de) | 1997-03-07 | 2007-06-15 | Clare Chemical Res Inc | Fluorometrischer nachweis mit sichtbarem light |
US6432360B1 (en) | 1997-10-10 | 2002-08-13 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US6511803B1 (en) | 1997-10-10 | 2003-01-28 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US20030096232A1 (en) | 1997-12-19 | 2003-05-22 | Kris Richard M. | High throughput assay system |
AU762728B2 (en) | 1998-07-02 | 2003-07-03 | Gen-Probe Incorporated | Molecular torches |
US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
US6573043B1 (en) | 1998-10-07 | 2003-06-03 | Genentech, Inc. | Tissue analysis and kits therefor |
US6303305B1 (en) | 1999-03-30 | 2001-10-16 | Roche Diagnostics, Gmbh | Method for quantification of an analyte |
DE60014762T2 (de) | 1999-05-24 | 2005-10-13 | Tosoh Corp., Shinnanyo | Methode zum Nachweis von Ribonukleinsäuren |
EP1218543A2 (en) | 1999-09-29 | 2002-07-03 | Solexa Ltd. | Polynucleotide sequencing |
AR031640A1 (es) | 2000-12-08 | 2003-09-24 | Applied Research Systems | Amplificacion isotermica de acidos nucleicos en un soporte solido |
EP1590477B1 (en) | 2003-01-29 | 2009-07-29 | 454 Corporation | Methods of amplifying and sequencing nucleic acids |
AU2004235747B2 (en) | 2003-05-01 | 2009-05-28 | Gen-Probe Incorporated | Oligonucleotides comprising a molecular switch |
AU2005280162B2 (en) | 2004-08-27 | 2012-04-26 | Gen-Probe Incorporated | Single-primer nucleic acid amplification methods |
EP2230316A1 (en) | 2005-02-01 | 2010-09-22 | AB Advanced Genetic Analysis Corporation | Nucleic acid sequencing by performing successive cycles of duplex extension |
CA2612021A1 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
US20090239223A1 (en) * | 2006-07-13 | 2009-09-24 | Siemens Healthcare Diagnostics Inc. | Prediction of Breast Cancer Response to Taxane-Based Chemotherapy |
US20080076121A1 (en) | 2006-09-22 | 2008-03-27 | Paul Kenneth Wolber | Microarray nuclease protection assay |
CA2778249C (en) | 2009-11-03 | 2018-12-04 | Htg Molecular Diagnostics, Inc. | Quantitative nuclease protection sequencing (qnps) |
-
2013
- 2013-03-06 WO PCT/IB2013/001032 patent/WO2013132354A2/en active Application Filing
- 2013-03-06 US US14/382,491 patent/US20150111758A1/en not_active Abandoned
- 2013-03-06 IN IN8312DEN2014 patent/IN2014DN08312A/en unknown
- 2013-03-06 AU AU2013229151A patent/AU2013229151A1/en not_active Abandoned
- 2013-03-06 CA CA2866254A patent/CA2866254A1/en not_active Abandoned
- 2013-03-06 EP EP13729075.5A patent/EP2823059A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2013132354A3 (en) | 2014-02-20 |
CA2866254A1 (en) | 2013-09-12 |
AU2013229151A1 (en) | 2014-09-25 |
EP2823059A2 (en) | 2015-01-14 |
WO2013132354A2 (en) | 2013-09-12 |
US20150111758A1 (en) | 2015-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017008421A (es) | Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga. | |
WO2013033609A3 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
IL257330B (en) | Preparations, methods and kits for diagnosing lung cancer | |
WO2014160499A3 (en) | Methods and compositions for detecting pancreatic cancer | |
EP3683320A3 (en) | Mirna fingerprint in the diagnosis of lung cancer | |
MX2019015159A (es) | Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica. | |
MX340453B (es) | Biomarcadores para cancer de pulmon. | |
MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
MX360141B (es) | Anticuerpos contra integrina alfavhbeta6 y uso de los mismos para tratar cancer. | |
HK1208501A1 (en) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis | |
MX2017010836A (es) | Panel biomarcador para la deteccion de cancer. | |
EP4356960A3 (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
MX341734B (es) | Biomarcadores para la prediccion de la eficacia de una inmunoterapia contra el cancer. | |
EA201400117A1 (ru) | Способы и нуклеиновые кислоты для определения прогноза у больных раком | |
PH12014501164A1 (en) | Anti-cd98 antibodies and methods of use thereof | |
HK1259001A1 (zh) | 癌症的預後和診斷方法 | |
EP2888370A4 (en) | DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES | |
WO2013106747A3 (en) | Methods and compositions for the treatment and diagnosis of thyroid cancer | |
MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
NZ729773A (en) | Biomarkers for disease progression in melanoma | |
WO2013052108A3 (en) | Methods and compositions for the treatment and diagnosis of ovarian cancer | |
EP3798316A3 (en) | Genes and gene signatures for diagnosis and treatment of melanoma | |
IN2014DN08312A (US06420169-20020716-C00020.png) | ||
WO2013169771A3 (en) | Methods and compositions for the prognosis and treatment of relapsed leukemia | |
WO2013081645A3 (en) | Erbb3 mutations in cancer |